ANI Pharma to buy Swedish biotech Egetis (ANIP:NASDAQ)
· seekingalpha.com
ANI Pharmaceuticals (ANIP) offers $560M to acquire Egetis (PDPHF), a Swedish rare disease drug developer. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...